J.P. Morgan Reiterates Overweight Rating On Covidien

According to J.P. Morgan, Covidien COV Overweight rating is reiterated. J.P. Morgan reported that the 2011 SAGES meeting is underway in San Antonio. “In the Endo-Mechanical markets, J&J has stolen the headlines at this year's meeting, introducing the first power stapler, while Covidien continues to roll out Tri-Staple and a series of high impact products from last year's meeting.” Covidien closed yesterday at $51.94.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsCovidienHealth CareHealth Care EquipmentJ.P.Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!